Related Experiment Video

Updated: May 23, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Statins and pregnancy: between supposed risks and theoretical benefits

Edouard Lecarpentier1, Olivier Morel, Thierry Fournier

  • 1Maternit Port-Royal, Cochin Hospital, AP-HP, Paris-Descartes University, Paris, France.

Drugs
|April 7, 2012
PubMed

Insights

Statins, used for cardiovascular risk reduction, are being increasingly used by pregnant women. This review examines the unclear teratogenic risks and potential benefits of statins in managing preeclampsia during pregnancy.

Area of Science:

  • Pharmacology
  • Cardiology
  • Obstetrics

Background:

  • Cardiovascular diseases are a leading cause of death globally.
  • Statins, HMG-CoA reductase inhibitors, are effective lipid-lowering drugs for primary cardiovascular prevention.
  • Increased maternal age and obesity lead to greater statin exposure during pregnancy.

Purpose of the Study:

  • To review the pharmacodynamic properties of statins.
  • To evaluate the teratogenic risks associated with statin use in pregnancy.
  • To explore the potential therapeutic benefits of statins in preeclampsia management.

Main Methods:

  • Literature review of statin pharmacodynamics.
  • Analysis of existing data on statin teratogenicity.
  • Examination of evidence for statin pleiotropic effects in preeclampsia.

Main Results:

  • Contradictory data exist regarding the teratogenic risk of statins.
  • Statins are currently contraindicated in pregnant women.
  • Pleiotropic vascular protective effects suggest potential benefits in preeclampsia.

Conclusions:

  • The teratogenic risk of statins in pregnancy remains unclear.
  • Statins may offer therapeutic potential for preeclampsia beyond lipid lowering.
  • Further research is needed to clarify risks and benefits for pregnant populations.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...